{"schema_version":"secwatch.filing_event.v1","accession":"0000950157-26-000700","form_type":"8-K","ticker":"BIIB","cik":"0000875045","company_name":"BIOGEN INC.","filed_at":"2026-06-10T20:54:22+00:00","discovered_at":"2026-06-10T20:55:00.268765+00:00","generated_at":"2026-06-10T20:55:10.656927+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Biogen shareholders elect all 10 director nominees and ratify auditor at 2026 annual meeting","bullets":["All ten board nominees elected; highest vote against for Eric K. Rowinsky (28.2M against of 121.9M voted).","PricewaterhouseCoopers ratified as auditor for FY2026 with 124.6M for, 6.6M against.","Advisory say-on-pay approved with 114.2M for, 7.5M against, 9.4M broker non-votes.","Meeting held June 9, 2026; results filed on Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950157-26-000700","json":"https://secwatch.observer/filing/0000950157-26-000700.json","markdown":"https://secwatch.observer/filing/0000950157-26-000700.md","text":"https://secwatch.observer/filing/0000950157-26-000700.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/0000950157-26-000700-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T20:55:10.656927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"85d02fc69f419fcc8a89cf7f2c44387dea6a61a2","claim":"BIOGEN INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-09 meeting.","evidence_excerpt":"Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/0000950157-26-000700-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"8bc021b0bb0f1af3594b96f1ce2608d13e462d18","claim":"BIOGEN INC. shareholders approved Advisory vote on executive compensation at the 2026-06-09 meeting.","evidence_excerpt":"Stockholders approved the advisory vote on executive compensation","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/0000950157-26-000700-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"c7ff18316f82ea64a2e900b60946c97795b5eb46","claim":"BIOGEN INC. shareholders approved Election of Directors at the 2026-06-09 meeting.","evidence_excerpt":"Stockholders elected ten nominees to the Board of Directors to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/0000950157-26-000700-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}